Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Avivagen Inc. (VIVXF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -27.5%, EPS growth of +23.4%, a dividend yield of 0.0%. What stands out right now is revenue -27.5%, EPS +23.4%, free cash flow +32.4% with operating margin -99.4% and ROIC -916.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VIVXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VIVXF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VIVXF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VIVXF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-27.5%
EPS Growth
+23.4%
Gross Margin
42.6%
Net Margin
-645.9%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.